Existing investors GE Asset Management, Kaiser Permanente, Integral Capital Partners, QuestMark Partners and Cross Creek Capital also participated in the current round.
The proceeds from this financing will be used to fund the company’s growth plans, it said.
Tony Arnerich, general partner of the 3×5 Special Opportunity Fund, and Jason Lettmann, Principal of Morgenthaler Venture Partners, both join the board of Directors.
“We are delighted to be a part of the Vapotherm story,” said Arnerich. “The unique technology and its clinical benefit for patients with a wide variety of breathing disorders is what appealed to our group. We look forward to supporting the company and its management team.”
In addition to closing the financing Vapotherm opened new corporate headquarters in Exeter, New Hampshire at the start of the year. The company manufactures advanced respiratory care devices based in Exeter, New Hampshire.
Copyright © 2013 AltAssets